Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06884982 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with Lenvatinib

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single-center, single-arm, prospective trial to explore the efficacy and safety of neoadjuvant treatment with Iparomlimab and Tuvonralimab Injection combined with lenvatinib in patients with advanced HCC
Trial Details
NCT Number NCT06884982
Lead Sponsor Northern Jiangsu People's Hospital
Conditions
(from sponsor)		 HCC - Hepatocellular Carcinoma
Related terms Carcinoma, Hepatocellular
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov